Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2008
11/27/2008US20080293660 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
11/27/2008US20080293659 FC gamma RIIA-specific nucleic acid interference
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293657 Modulation of the expression of stat-1-dependent genes
11/27/2008US20080293656 Processing nucleic acid
11/27/2008US20080293655 Novel tandem siRNAS
11/27/2008US20080293653 Method of treating autoimmune diseases
11/27/2008US20080293652 Combination of Ad-P53 and Chemotherapy for the Treatment of Tumours
11/27/2008US20080293640 Polypeptide inhibitors of HSP27 kinase and uses therefor
11/27/2008US20080293636 Protein Constructs Designed for Targeting and Lysis of Cells
11/27/2008US20080293629 Albumin Fusion Proteins
11/27/2008US20080293627 Thyrotropin Receptor Preparations, Binding Regions Thereof, Antibody and Hormone Interactions Therewith, and Uses Thereof
11/27/2008US20080293611 Polyol oxidases
11/27/2008US20080293610 Use and production of storage-stable neutral metalloprotease
11/27/2008US20080293607 Alkaliphilic Bacillus Species alpha-Amylase Variants, Compositions Comprising alpha-Amylase Variants, And Methods of Use
11/27/2008US20080293595 siRNA targeting protein tyrosine phosphatase-1B (PTP1B)
11/27/2008US20080293593 siRNA targeting casitas B cell lymphoma-B (CBL-B)
11/27/2008US20080293155 Salicylamide-lanthanide complexes for use as luminescent markers
11/27/2008US20080293143 Generation of human embryonc stem-like cells using intronic RNA
11/27/2008US20080293142 Multiple shRNA Expression Vectors and Methods of Construction
11/27/2008US20080293141 Cell for Producing Retrovirus Vector
11/27/2008US20080293136 Nucleic acid compounds for inhibiting akt gene expression and uses thereof
11/27/2008US20080293134 Human Cancer Suppressor Gene, Protein Encoded Therein, Expression Vector Containing Same
11/27/2008US20080293124 Multimeric Oxidoreductases
11/27/2008US20080293123 Compositions comprising viruses and methods for concentrating virus preparations
11/27/2008US20080293121 Human dnase i hyperactive variants
11/27/2008US20080293120 lipolytic enzymes variants
11/27/2008US20080293118 Magnetic fine particles having lower critical solution temperature
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080293115 Plant wall degradative compounds and systems
11/27/2008US20080293112 Succinic acid-producing bacterium and process for producing succinic acid
11/27/2008US20080293108 Hyaluronate synthase gene and uses thereof
11/27/2008US20080293103 Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
11/27/2008US20080293102 Compositions and methods for producing apolipoprotein
11/27/2008US20080293099 Lignan Glycosidase and Utilization of the Same
11/27/2008US20080293098 Dna Encoding Novel Enzyme Having D-Serine Synthase Activity, Method of Producing the Enzyme and Method of Producing D-Serine by Using the Same
11/27/2008US20080293087 Sulfonylurea receptor short forms from mitochondria and uses thereof
11/27/2008US20080293086 Real time monitoring of microbial enzymatic pathways
11/27/2008US20080293077 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
11/27/2008US20080293053 shRNA Materials and Methods of Using Same for Inhibition of DKK-1
11/27/2008US20080293046 RNA detection assays
11/27/2008US20080293043 Method of Detecting Metastisizing Cancer Cells Originating in Stomach Cancer
11/27/2008US20080293040 Influenza b viruses with reduced sensitivity to neuraminidase inhibitors
11/27/2008US20080293035 Nucleic Acid Isolation
11/27/2008US20080292753 Polypeptides Having Phytase Activity and Polynucleotides Encoding Same
11/27/2008US20080292735 Regulating alkaloids
11/27/2008US20080292732 Plant and Plant Storage Organ Having Glp-1 Derivative Accumulated Therein and Method of Producing the Same
11/27/2008US20080292704 Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins
11/27/2008US20080292688 Liposome and preparation method of the same
11/27/2008US20080292662 Vaccine Comprising Recombinant Clpp Protein of Streptococcus Pneumoniae
11/27/2008US20080292657 Primate t-lymphotropic viruses
11/27/2008US20080292655 Enhancement of the immune response for vaccine and gene therapy applications
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292652 Virus-Like Particles Comprising a Fusion Protein of the Coat Protein of Ap205 and an Antigenic Polypeptide
11/27/2008US20080292648 Synthetic agonists of tlr9
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292646 Recombinant fusion protein and polynucleotide construct for immunotoxin production
11/27/2008US20080292641 Antigenic GM-CSF peptides and antibodies to GM-CSF
11/27/2008US20080292639 Humanized Anti-Amyloid Antibody
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
11/27/2008US20080292635 Allergenic latex protein
11/27/2008US20080292634 Nontypable Haemophilus Infuenzae Virulence Factors
11/27/2008US20080292633 Compositions and methods for the therapy and diagnosis of lung cancer
11/27/2008US20080292632 Irta2 Antibodies and Methods of Use
11/27/2008US20080292628 Chimeric Protein
11/27/2008US20080292624 Method of detecting and treating tuberous sclerosis complex associated disorders
11/27/2008US20080292623 Mammalian cell membrane proteins; related reagents
11/27/2008US20080292620 PRLR-Specific Antibody and Uses Thereof
11/27/2008US20080292617 Antibody against a peptide derived from human mutant lamin a protein and uses thereof
11/27/2008US20080292615 Diagnosis and treatment of disease
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292594 reduced expression of a sigma3 polypeptide; used to generate and stably propagate infectious subviral particle (ISVP); proliferative disorder
11/27/2008US20080292592 treating, preventing cancer using compositions including replication competent adenovirus; death domains; rapid and efficient spread through the tumor
11/27/2008US20080292581 Interleukin-11 Fusion Proteins
11/27/2008US20080292549 High Affinity Melan-A T Cell Receptors
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008DE102007024086A1 Nucleic acid coding for a signal peptide for producing recombinant proteins in secreted form has a restriction site in the vicinity of its 3' end
11/27/2008DE102007024085A1 Nukleinsäuremoleküle codierend für ein Protein mit Deacetylase-Aktivität, besagtes Protein, sowie Verfahren zur Herstellung von Chitosan Nucleic acid molecules coding for a protein having deacetylase activity, said protein, and to methods for preparing chitosan
11/27/2008CA2724454A1 Method of identifying compounds that modulate regulation of iron respon se elements
11/27/2008CA2715093A1 Engineered microorganisms for producing n-butanol and related methods
11/27/2008CA2702676A1 Methods of genome installation in a recipient host cell
11/27/2008CA2690825A1 Fusion molecules and il-15 variants
11/27/2008CA2689677A1 Improvements in or relating to organic compounds
11/27/2008CA2688829A1 Novel rabbit antibody humanization methods and humanized rabbit antibodies
11/27/2008CA2688724A1 Novel simian t-cell lymphotropic virus
11/27/2008CA2688571A1 Methods of directly amplifying nucleic acids from crude samples
11/27/2008CA2688536A1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cancer
11/27/2008CA2688146A1 Antibodies to il-6 and use thereof
11/27/2008CA2687844A1 Tumor suppressor gene screening using rna interference libraries and method of treatment
11/27/2008CA2687760A1 Polynucleotide markers
11/27/2008CA2687635A1 Plant cells and plants with increased tolerance and/or resistance to environmental stress and increased biomass production-ko
11/27/2008CA2687633A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008CA2687627A1 Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
11/27/2008CA2687605A1 Methods and means for producing glycoproteins with altered glycosylation pattern in higher plants
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687493A1 Recombinant protein production in avian ebx r cells
11/27/2008CA2687422A1 Composition and method for modulating plant root hair development
11/27/2008CA2687170A1 Method for producing a recombinant protein on a manufacturing scale
11/27/2008CA2687117A1 Single-chain fc (scfc) regions, binding polypeptides comprising same, and methods related thereto
11/27/2008CA2685848A1 Plants having enhanced yield-related traits and a method for making the same
1 ... 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 ... 4023